ST
Therapeutic Areas
Insight Molecular Diagnostics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Blood-based transplant monitoring test | Post-transplant organ rejection monitoring | Commercial/Clinical |
| Clinical assay for dd-cfDNA quantification | Kidney transplant surveillance | In development |
| Research-use-only dd-cfDNA test kit | Transplant monitoring research | Research Use Only |
| Genomic copy number instability test | Cancer therapeutic efficacy monitoring | In development |
| 27-gene expression laboratory developed test | Immunotherapy response prediction | In development |
| Research-use-only 27-gene expression assay | Tumor immune microenvironment research | Research Use Only |
Leadership Team at Insight Molecular Diagnostics
JR
Josh Riggs
President & Chief Executive Officer
PD
Prof. Dr. Ekkehard Schütz, MD, PhD, FAACC
Chief Science Officer
Y(
Yuh-Min (Johnson) Chiang, PhD
Chief Technology Officer
AJ
Andrea James
Chief Financial Officer
SO
Sandra O'Donald
Senior Vice President, Business Operations
RA
Ryan Andrews
Vice President, Commercial
PH
Peter Hong
Vice President, General Counsel
JL
James Liu
Vice President of Accounting, Controller, Treasurer, and Principal Accounting Officer
DN
Dr. Nick Ioannou, MD, PhD, MHA
Vice President, Medical Affairs in Transplantation